Page 4 - Trials Network News Today

We need to think about that. Im not sure theres any nearterm solutions to this, but it was another one of those dark, dark and somewhat implicit implications for this terrible tragedy. Thank you. Thanks. I actually want to pick up on one thing you said and then come to a couple of you as well around some of the turning points. I agree, that speech that president clinton made was quite extraordinary and im not sure everybody it got the attention it needed given how extraordinary it was. But the o...

To get state legislatures, and then the Republican Congress to supplant the will of the people. Its extremely doubtful we ever get that far. Theres no indication the president s efforts to gum up the works by getting alternative electors slated will succeed. He leaned on michigan legislators on friday and is said to be trying to do likewise with pennsylvanians, although pennsylvania lawmakers say they havent received an invitation to the white house. After meeting with the president , the Michig...

And katrina, and the pearl harbor attack. The u. S. Also seat new record for people hospitalized with coronavirus. Another 2,000person increase in just one day, meaning 107,000 people are waking up in the hospital this morning. The fda panel meets this morning to decide on that emergency use authorization of the pfizer Coronavirus Vaccine. If approved today, the first doses could be administered within days. That is good news for the republic, even as the president tries to undermine democracy a...

This is a hearing about the pat, Patient Involvement in fda drug approvals, and i think we can agree they deserve a seat at the table. When companies are developing drugs and medical devices within the Clinical Trial process. I have long been a supporter of the department of defenses congressionallydirected medical Research Program known as the cdmrp. It funds peerreviewed research into Breast Cancer, autism, ovarian cancer, Prostate Cancer and other diseases. And since 1993 the patients have be...

Trials because they are being treated in places that are not running trials. We need to move this out in to the community, make those folks eligible. And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working ...

And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working on and how to do Clinical Trials utilizing the infrastructure that is emerging. Right, thank you very much. Chair, thanks, gentle lady, and now recogn...

Government, as wellintentioned as they are, and i do believe that they are wellintentioned, i just simply do not think that they have the capacity. I think that there needs to be something to augment their capacity. I think that there needs to be some kind of coordination unit. Ive heard here today that the World Health Organization has the lead. Maybe, maybe not. I think something with a bit more of an operational edge to it is called for. That may be some kind of a i do not know what that coul...

Uganda Aids Commission says more than 50,000 Ugandans contract HIV every year, with around 17,000 HIV-related deaths among the estimated 1.4 million Ugandans living with HIV

​​This is the second of six seminars that the LSHTM Clinical Trials Network is running in 2024 on practical issues in clinical trials.  Speakers​Dr Anna Last, LSHTMDr Anna Last is a clinical associate professor from LSHTM, who will present on the logistical considerations and preparation required to conduct a cluster randomised trial, using the example of the MATAMAL trial.

The existing BCG vaccine has limited effect on pulmonary tuberculosis